The MEFV variants in patients with familial Mediterranean fever and their clinical correlations

In patients with M694V mutation, it was found that age of onset of FMF symptoms, age of diagnosis, and age of treatment initiation were younger (p=0.003, p=0.014, p=0.025).

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background: Familial Mediterranean Fever (FMF) is the most common auto-inflammatory disease characterized by recurrent attacks.

📊

Key Findings & Data:The mutation in the MEFV gene located at the short arm of the 16th chromosome impairs the encoding of the pyrin protein.

💡

Conclusion & Impact:In patients with M694V mutation, it was found that age of onset of FMF symptoms, age of diagnosis, and age of treatment initiation were younger (p=0.003, p=0.014, p=0.025).

🔬Design:Research Article

📍Scope:2010 Verileri

⚙️Variables:Familial Mediterranean Fever · MEFV gene

Özet

Background: Familial Mediterranean Fever (FMF) is the most common auto-inflammatory disease characterized by recurrent attacks. FMF was found to be correlated with the mutation in MEFV gene. The mutation in the MEFV gene located at the short arm of the 16th chromosome impairs the encoding of the pyrin protein. Until now, numerous variants of the MEFV gene have been identified. Patients with M694V homozygous mutation have been reported to have a more severe disease. However, there is no clear study of clinical correlation in other variants. In this study, we aimed to investigate the frequency and clinical correlation of MEFV gene variants. Methods: Electronic medical records of FMF cohort were retrospectively analyzed. FMF cohort was established in year 2010 and since then all patients who fulfilled Tel-Hashomer criteria Demographic information, attack characteristics, treatment information and MEFV gene outcomes of the patients were analysed using the records. In MEFV gene analysis, M694V, M694I, M680I, V726A, R761H, A744S, F479L, P369S, R202Q and E148Q variants are evaluated. Results: A total of 605 patients were included in the study. In patients who had M694V mutation, arthritis and erysipelas were observed more frequently (p=0.04, p=0.008). Increased family history of FMF was identified in patients with M694V mutation (p<0.001). In patients with M694V mutation, it was found that age of onset of FMF symptoms, age of diagnosis, and age of treatment initiation were younger (p=0.003, p=0.014, p=0.025). In patients with M694V homozygous, frequency of amyloidosis was higher (p<0.001). The risk of developing amyloidosis was higher in M694V homozygous (Odds ratio 7.46, 95% confidence interval: 2.92-19.05). Conclusions: In conclusion, homozygous M694V mutation leads to severe disease. There was no clinical variability in other MEFV gene variants.

Keywords

Familial Mediterranean Fever MEFV gene

🔖

Cite This Article

SALMAN, R. B., TUFAN, A., VARAN, Ö., GÖKER, B., ÖZTÜRK, M. A., KÜÇÜK, H., BABAOĞLU, H., ATAŞ, N., SATIŞ, H., HAZNEDAROĞLU, S. (2022). The MEFV variants in patients with familial Mediterranean fever and their clinical correlations. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 52 - Sayı: 2, 162–166. https://ajindex.com/articles/441259

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Gershoni-Baruch R, Brik R, Shinawi M, Livneh A (2002) The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10 (2):145-149. doi:10.1038/sj.ejhg.5200776 2. Ben-Chetrit E, Touitou I (2012) The impact of MEFV gene identification on FMF: an appraisal after 15 years. Clin Exp Rheumatol 30 (3 Suppl 72):S3-6 3. French FMFC (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17 (1):25-31. doi:10.1038/ng0997-25 4. Tufan A, Babaoglu MO, Akdogan A et al. (2007) Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol 34 (7):1540-1544 5. Chae JJ, Cho YH, Lee GS et al. (2011) Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 34 (5):755-768. doi:10.1016/j.immuni.2011.02.020 6. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10 (2):417-426 7. Infevers (2018) The registry of familial Mediterranean fever (FMF) and hereditary autoinflammatory disorders mutations. http://fmf.igh.cnrs.fr/ISSAID/infevers/. 8. Fujikura K (2015) Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. Mol Genet Genomic Med 3 (4):272-282. doi:10.1002/mgg3.140 9. Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T (2005) MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 25 (4):255-259. doi:10.1007/s00296-003-0433-x 10. Yalcinkaya F, Cakar N, Misirlioglu M et al. (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford) 39 (1):67-72 11. Ece A, Cakmak E, Uluca U et al. (2014) The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey. Rheumatol Int 34 (2):207-212. doi:10.1007/s00296-013-2858-1 12. Jarjour RA (2010) Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation. Mol Biol Rep 37 (1):1-5. doi:10.1007/s11033-009-9475-9 13. Dewalle M, Domingo C, Rozenbaum M et al. (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6 (1):95-97. doi: